Your browser doesn't support javascript.
loading
Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity.
Cao, Jing-Ke; Han, Tao; Tang, Hong-Yi; Zhang, Sheng; Wang, Zong-Hua; Feng, Zhi-Chun; Li, Qiu-Ping.
Afiliación
  • Cao JK; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
  • Han T; Department of Neonatology, Senior Department of Pediatrics, The Seventh Medical Center of Chinese PLA General Hospital, NO.5 Nanmencang, Dongcheng District, Beijing, 100700, China.
  • Tang HY; The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China.
  • Zhang S; Department of Neonatology, Senior Department of Pediatrics, The Seventh Medical Center of Chinese PLA General Hospital, NO.5 Nanmencang, Dongcheng District, Beijing, 100700, China.
  • Wang ZH; Department of Ophthalmology, the Seventh Medical Center of Chinese PLA General Hospital, Beijing, 100700, China.
  • Feng ZC; Department of Neonatology, Senior Department of Pediatrics, The Seventh Medical Center of Chinese PLA General Hospital, NO.5 Nanmencang, Dongcheng District, Beijing, 100700, China.
  • Li QP; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China. zhjhospital@163.com.
BMC Ophthalmol ; 23(1): 137, 2023 Apr 04.
Article en En | MEDLINE | ID: mdl-37016343
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Ranibizumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans / Infant / Newborn Idioma: En Revista: BMC Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Ranibizumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans / Infant / Newborn Idioma: En Revista: BMC Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China